Skip to main content

Table 3 Outcomes of the study population

From: Impact of the COVID-19 pandemic and post-epidemic periods on the process of endovascular treatment for acute anterior circulation ischaemic stroke

 

Pre-pandemic group(n = 32)

Pandemic group(n = 23)

Post-epidemic group(n = 39)

P* value

P** value

P*** value

sICH, n (%)

3(9.4)

4(17.4)

3(7.7)

0.435

0.999

0.408

Reperfusion mTICI 2b/3

25(78.1)

17(73.9)

36(92.3)

0.717

0.168

0.066

90-day mRS ≤ 2, n (%)

18(56.3)

14(60.9)

24(61.5)

0.732

0.652

0.958

90-day mRS, median (IQR)

2(0,4)

2(1,5)

2(1,4)

0.650

0.612

0.894

90-day mortality, n (%)

6(18.8)

5(21.7)

8(20.5)

0.999

0.853

0.999

  1. P* Pre-pandemic group vs. Pandemic group, P** Pre-pandemic group vs. Post-epidemic group,
  2. P*** Pandemic group vs. Post-epidemic group,
  3. NIHSS National Institutes of Health Stroke scale, sICH Symptomatic intracranial haemorrhage transformation, mTICI Modified Treatment in Cerebral Infarction, mRS Modified Rankin Scale, IQR Interquartile range (25%–75%)